Skip to main content

Table 1 Demographics of transplant cohort

From: The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients

Variable

N = 60

Female (%)

28 (46.7)

Deceased donor (%)

32 (53.3)

Ethnicity (%)

 

 -Caucasian

34 (57)

 -East Asian

16 (26.7)

 -South Asian

5 (8.3)

 -Black

2 (3.3)

 -Other

3 (5.0)

Age at conversion

53.9 ± 9.5

Years post-transplant

7.4 ± 3.8

eGFR at conversion (ml/min)

62 ± 36.2

Tac BID dose pre-conversion (mg/day)

3.1 ± 1.0

Tac OD dose 12 months post-conversion (mg/day)

3.8 ± 1.3*

[Tac C0 BID] pre-conversion (ng/ml)

5.2 ± 1.6

[Tac CO OD] post-conversion (ng/ml)

5.1 ± 1.5

  1. BID twice daily, OD once daily, Tac tacrolimus
  2. *p = 0.007 for Tac dose BID versus OD